Agrawal, R. et al. (2011) ‘Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model’, European Neuropsychopharmacology, 21(3), pp. 261–273. doi: 10.1016/j.euroneuro.2010.11.009.
Alejandre-Gomez, M., Garcia-Segura, L. M. and Gonzalez-Burgos, I. (2007) ‘Administration of an inhibitor of estrogen biosynthesis facilitates working memory acquisition in male rats.’, Neuroscience research, 58(3), pp. 272–277. doi: 10.1016/j.neures.2007.03.011.
Aydin, M. et al. (2008) ‘Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.’, Neuroscience, 151(1), pp. 186–194. doi: 10.1016/j.neuroscience.2007.09.005.
Bakker, R., Tiesinga, P. and Kötter, R. (2015) ‘The Scalable Brain Atlas: Instant Web-Based Access to Public Brain Atlases and Related Content’, Neuroinformatics. Humana Press Inc., 13(3), pp. 353–366. doi: 10.1007/s12021-014-9258-x.
Balbaa, M., Abdulmalek, S. A. and Khalil, S. (2017) ‘Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs’, PLoS ONE. Public Library of Science, 12(5). doi: 10.1371/journal.pone.0172429.
Bian, C. et al. (2019) ‘17β-Estradiol Regulates Glucose Metabolism and Insulin Secretion in Rat Islet β Cells Through GPER and Akt/mTOR/GLUT2 Pathway’, Frontiers in Endocrinology, 10, p. 531. doi: 10.3389/fendo.2019.00531.
Buonfiglioli, A. et al. (2019) ‘let-7 MicroRNAs Regulate Microglial Function and Suppress Glioma Growth through Toll-Like Receptor 7’, Cell Reports. Elsevier B.V., 29(11), pp. 3460-3471.e7. doi: 10.1016/j.celrep.2019.11.029.
Chang, P. K.-Y. et al. (2013) ‘Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid.’, Journal of aging research, 2013, p. 538979. doi: 10.1155/2013/538979.
Chen, P. S. et al. (2011) ‘miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans’, Journal of Clinical Investigation, 121(9), pp. 3442–3455. doi: 10.1172/JCI45390.
Cho, S. et al. (2016) ‘Aromatase inhibitor regulates let-7 expression and let-7f-induced cell migration in endometrial cells from women with endometriosis.’, Fertility and sterility. NIH Public Access, 106(3), pp. 673–80.
Cogswell, J. et al. (2008) ‘Identification of miRNA Changes in Alzheimer’s.pdf’, Journal of Alzheimer’s Disease, 14, pp. 27–41.
Cold spring harbor (2011) ‘Artificial cerebrospinal fluid (ACSF)’, Cold Spring Harbor Protocols. Cold Spring Harbor Laboratory, 2011(9). doi: 10.1101/pdb.rec065730.
Dave, N., Gudelsky, G. A. and Desai, P. B. (2013) ‘The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.’, Cancer chemotherapy and pharmacology, 72(2), pp. 349–357. doi: 10.1007/s00280-013-2205-y.
Davey, D. A. (2017) ‘Prevention of Alzheimer’s disease, cerebrovascular disease and dementia in women: the case for menopause hormone therapy’, Neurodegenerative disease management, 7(1), pp. 85–94. doi: 10.2217/nmt-2016-0044.
Deacon, R. M. J. J. and Rawlins, J. N. P. (2006) ‘T-maze alternation in the rodent’, Nature Protocols, 1(1), pp. 7–12. doi: 10.1038/nprot.2006.2.
Derkow, K. et al. (2018) ‘Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer’s disease’, PLoS ONE. Public Library of Science, 13(7), pp. 1–18. doi: 10.1371/journal.pone.0200602.
Desjardins, P. and Conklin, D. (2010) ‘NanoDrop microvolume quantitation of nucleic acids’, Journal of Visualized Experiments. Journal of Visualized Experiments, (45), p. 2565. doi: 10.3791/2565.
DeTure, M. A. and Dickson, D. W. (2019) ‘The neuropathological diagnosis of Alzheimer’s disease’, Molecular Neurodegeneration, 14(1), p. 32. doi: 10.1186/s13024-019-0333-5.
Eleazu, C. O. et al. (2013) ‘Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans’, Journal of Diabetes and Metabolic Disorders. BioMed Central Ltd., 12(1), p. 60. doi: 10.1186/2251-6581-12-60.
Francess, E. M. et al. (2018) ‘Modulation of LIN28B/let-7 signaling by propranolol contributes to infantile hemangioma involution’, Arteriosclerosis, Thrombosis, and Vascular Biology. Lippincott Williams and Wilkins, 38(6), pp. 1321–1332. doi: 10.1161/ATVBAHA.118.310908.
Frick, K. M. (2019) Estrogens and Memory: Basic Research and Clinical Implications. Oxford University Press (Oxford Series in Behavioral Neuroendocrinology).
Frost, R. J. A. and Olson, E. N. (2011) ‘Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs’, Proceedings of the National Academy of Sciences of the United States of America, 108(52), pp. 21075–21080. doi: 10.1073/pnas.1118922109.
Gámez-Valero, A. et al. (2019) ‘Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies’, Translational Neurodegeneration. BioMed Central Ltd., 8(1), p. 31. doi: 10.1186/s40035-019-0169-5.
Grünblatt, E. et al. (2007) ‘Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein’, Journal of Neurochemistry, 101(3), pp. 757–770. doi: 10.1111/j.1471-4159.2006.04368.x.
Gu, H. et al. (2017) ‘Overexpression of let-7a increases neurotoxicity in a PC12 cell model of Alzheimer’s disease via regulating autophagy.’, Experimental and therapeutic medicine. Spandidos Publications, 14(4), pp. 3688–3698. doi: 10.3892/etm.2017.4977.
Gupta, S. et al. (2018) ‘Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer’s Disease’, Molecular Neurobiology. Humana Press Inc., 55(12), pp. 8916–8935. doi: 10.1007/s12035-018-0985-0.
Hara, N. et al. (2017) ‘Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease’, Acta Neuropathologica Communications, 5(1), p. 10. doi: 10.1186/s40478-017-0414-z.
Van Harten, A. C. et al. (2015) ‘Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer’s Disease’, Journal of Alzheimer’s Disease. IOS Press, 47(1), pp. 243–252. doi: 10.3233/JAD-140075.
Hau, J. and Schapiro, S. J. (2002) Handbook of Laboratory Animal Science: Essential Principles and Practices. 2nd edn. CRC Press.
Herrera-Espejo, S. et al. (2019) ‘A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease’, Molecular Neurobiology. Humana Press Inc., 56(12), pp. 8376–8391. doi: 10.1007/s12035-019-01676-9.
Honda, K. et al. (2000) ‘Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons’, Journal of Neuroscience Research, 60(3), pp. 321–327. doi: 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.0.CO;2-T.
Isanejad, A. et al. (2016) ‘MicroRNA-206, Let-7 and microRNA-21 pathways involved in the anti-angiogenesis effects of the interval exercise training and hormone therapy in breast cancer’, Life Sciences. Elsevier B.V., 151, pp. 30–40. doi: 10.1016/j.lfs.2016.02.090.
Islam, Fakhrul et al. (2015) ‘Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice’, Journal of the Neurological Sciences. Elsevier, 348(1–2), pp. 51–59. doi: 10.1016/j.jns.2014.10.044.
Jiang, S. (2019) ‘A Regulator of Metabolic Reprogramming: MicroRNA Let-7’, Translational Oncology. Neoplasia Press, Inc., 12(7), pp. 1005–1013. doi: 10.1016/j.tranon.2019.04.013.
Kamat, P. K. et al. (2016) ‘Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology’, Molecular Neurobiology. Humana Press Inc., 53(7), pp. 4548–4562. doi: 10.1007/s12035-015-9384-y.
Kenny, A. et al. (2019) ‘Elevated Plasma microRNA-206 Levels Predict Cognitive Decline and Progression to Dementia from Mild Cognitive Impairment’, Biomolecules, 9(11), p. 734. doi: 10.3390/biom9110734.
Kil, K. E. et al. (2009) ‘Synthesis and PET studies of [11C-cyano]letrozole (Femara), an aromatase inhibitor drug’, Nuclear Medicine and Biology, 36(2), pp. 215–223. doi: 10.1016/j.nucmedbio.2008.11.010.
Kjonigsen, L. J. et al. (2015) ‘Waxholm Space atlas of the rat brain hippocampal region: Three-dimensional delineations based on magnetic resonance and diffusion tensor imaging’, NeuroImage. Academic Press Inc., 108, pp. 441–449. doi: 10.1016/j.neuroimage.2014.12.080.
Kumar, P. et al. (2013) ‘Circulating miRNA Biomarkers for Alzheimer’s Disease’, PLoS ONE, 8(7). doi: 10.1371/journal.pone.0069807.
De La Monte, S. M. and Wands, J. R. (2005) ‘Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer’s disease’, Journal of Alzheimer’s Disease. IOS Press, 7(1), pp. 45–61. doi: 10.3233/JAD-2005-7106.
Lane, C. A., Hardy, J. and Schott, J. M. (2018) ‘Alzheimer’s disease’, European Journal of Neurology. John Wiley & Sons, Ltd (10.1111), 25(1), pp. 59–70. doi: 10.1111/ene.13439.
Langhans, W. et al. (2016) ‘Routine animal use procedures’, University of Zurich, Institute of Laboratory Animal Science, (June), pp. 1–34.
Lee, C.-W. et al. (2013) ‘Hypoglycemia Induces Tau Hyperphosphorylation’, Current Alzheimer Research. Bentham Science Publishers Ltd., 10(3), pp. 298–308. doi: 10.2174/1567205011310030009.
Lee, H. et al. (2016) ‘Biogenesis and regulation of the let-7 miRNAs and their functional implications.’, Protein & cell. Springer, 7(2), pp. 100–13. doi: 10.1007/s13238-015-0212-y.
Lehmann, S. M. et al. (2012) ‘An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration.’, Nature neuroscience, 15(6), pp. 827–35. doi: 10.1038/nn.3113.
Lin, Y. Te et al. (2009) ‘Increased total TAU but not amyloid-β42; In cerebrospinal fluid correlates with short-term memory impairment in Alzheimer’s disease’, Journal of Alzheimer’s Disease. IOS Press, 18(4), pp. 907–918. doi: 10.3233/JAD-2009-1214.
Liu, Q. Y. et al. (2014) ‘Identification of microRNAs involved in Alzheimer’s progression using a rabbit model of the disease.’, American journal of neurodegenerative disease, 3(1), pp. 33–44.
Livak, K. J. and Schmittgen, T. D. (2001) ‘Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method’, Methods. Academic Press Inc., 25(4), pp. 402–408. doi: 10.1006/meth.2001.1262.
Lozier, A. M. et al. (2015) ‘Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma’, Oncotarget. Impact Journals LLC, 6(1), pp. 196–206. doi: 10.18632/oncotarget.2768.
Lv, Z. et al. (2018) ‘Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation’, Metabolic Brain Disease. Springer New York LLC, 33(5), pp. 1711–1720. doi: 10.1007/s11011-018-0279-2.
Mehla, J., Pahuja, M. and Gupta, Y. K. (2013) ‘Streptozotocin-Induced Sporadic Alzheimer ’ s Disease : Selection of Appropriate Dose’, Journal of Alzheimer’s disease : JAD, 33(1), pp. 17–21. doi: 10.3233/JAD-2012-120958.
Mishra, S. K. et al. (2018) ‘Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats’, Neurochemistry International. Elsevier Ltd, 113, pp. 56–68. doi: 10.1016/j.neuint.2017.11.012.
Nayebi, A. M., Pourrabi, S. and Hossini, S. (2014) ‘Testosterone ameliorates streptozotocin-induced memory impairment in male rats’, Acta Pharmacologica Sinica, 35(6), pp. 752–757. doi: 10.1038/aps.2014.6.
Papp, E. A. et al. (2014) ‘Waxholm Space atlas of the Sprague Dawley rat brain’, NeuroImage. Academic Press Inc., 97, pp. 374–386. doi: 10.1016/j.neuroimage.2014.04.001.
Parachikova, A. et al. (2007) ‘Inflammatory changes parallel the early stages of Alzheimer disease’, Neurobiology of Aging, 28(12), pp. 1821–1833. doi: 10.1016/j.neurobiolaging.2006.08.014.
Pase, M. P. et al. (2019) ‘Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes’, JAMA Neurology. American Medical Association, 76(5), pp. 598–606. doi: 10.1001/jamaneurol.2018.4666.
Paxinos, G. and Watson, C. (2006) The rat brain in stereotaxic coordinates: hard cover edition. Elsevier.
Peixoto, P. et al. (2017) ‘GPER agonist dilates mesenteric arteries via PI3K-Akt-eNOS and potassium channels in both sexes’, Life Sciences. Elsevier Inc., 183, pp. 21–27. doi: 10.1016/j.lfs.2017.06.020.
Peng, D. et al. (2013) ‘Hyperphosphorylation of tau protein in hippocampus of central insulin-resistant rats is associated with cognitive impairment’, Cellular Physiology and Biochemistry, 32(5), pp. 1417–1425. doi: 10.1159/000356579.
Perl, D. P. (2010) ‘Neuropathology of Alzheimer’s disease’, Mount Sinai Journal of Medicine, 77(1), pp. 32–42. doi: 10.1002/msj.20157.
Qu, Z. et al. (2011) ‘Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain’, Brain Research, 1383, pp. 300–306. doi: 10.1016/j.brainres.2011.01.084.
Rivera, E. J. et al. (2005) ‘Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine’, Journal of Alzheimer’s Disease. IOS Press, 8(3), pp. 247–268. doi: 10.3233/JAD-2005-8304.
Salkovic-Petrisic, M. and Hoyer, S. (2007) ‘Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach’, in Neuropsychiatric Disorders An Integrative Approach. Springer Vienna, pp. 217–233. doi: 10.1007/978-3-211-73574-9_28.
Schmittgen, T. D. and Livak, K. J. (2008) ‘Analyzing real-time PCR data by the comparative CT method’, Nature Protocols, 3(6), pp. 1101–1108. doi: 10.1038/nprot.2008.73.
Sergejeva, M. et al. (2015) ‘Anatomical landmarks for registration of experimental image data to volumetric rodent brain atlasing templates’, Journal of Neuroscience Methods. Elsevier, 240, pp. 161–169. doi: 10.1016/j.jneumeth.2014.11.005.
Shamsuzzama et al. (2016) ‘Role of MicroRNA Let-7 in Modulating Multifactorial Aspect of Neurodegenerative Diseases: an Overview’, Molecular Neurobiology, 53(5), pp. 2787–2793. doi: 10.1007/s12035-015-9145-y.
Shi, L. et al. (2017) ‘A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model’, Behavioural Brain Research. Elsevier B.V., 327, pp. 65–74. doi: 10.1016/j.bbr.2017.03.032.
Shibahara, Y. et al. (2012) ‘Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f , a microRNA targeting CYP19A1’, The Journal of Pathology, 227(April), pp. 357–366. doi: 10.1002/path.4019.
Silva, R. H. et al. (2004) ‘Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice’, Neuropharmacology, 46(6), pp. 895–903. doi: 10.1016/j.neuropharm.2003.11.032.
Sørensen, S. S., Nygaard, A. B. and Christensen, T. (2016) ‘miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia - an exploratory study’, Translational Neurodegeneration. BioMed Central Ltd., 5(1). doi: 10.1186/s40035-016-0053-5.
Spijker, S. (2011) ‘Dissection of rodent brain regions’, Neuromethods, 57, pp. 13–26. doi: 10.1007/978-1-61779-111-6_2.
Sung, Y. et al. (2019) ‘Lin28a expression protects against streptozotocin-induced β-cell destruction and prevents diabetes in mice’, Cell Biochemistry and Function. John Wiley and Sons Ltd, 37(3), pp. 139–147. doi: 10.1002/cbf.3376.
Swarbrick, S. et al. (2019) ‘Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease’, Molecular Neurobiology. Humana Press Inc., 56(9), pp. 6156–6167. doi: 10.1007/s12035-019-1500-y.
Tan, Lin et al. (2014) ‘Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer’s disease’, Journal of Alzheimer’s Disease. IOS Press, 40(4), pp. 1017–1027. doi: 10.3233/JAD-132144.
The University of Texas at Austin (2013) ‘Guidelines for the Use of Cervical Dislocation for Rodent Euthanasia The University of Texas at Austin Institutional Animal Care and Use Committee’, pp. 1–2.
Wang, J. H. et al. (2006) ‘Ketamine affects memory consolidation: Differential effects in T-maze and passive avoidance paradigms in mice’, Neuroscience, 140(3), pp. 993–1002. doi: 10.1016/j.neuroscience.2006.02.062.
Wang, L. et al. (2017) ‘Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer ’ s Disease’, 2017.
Wang, L. L. et al. (2017) ‘Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer’s Disease’, BioMed Research International. Hindawi Limited, 2017, p. 8030369. doi: 10.1155/2017/8030369.
Wang, W. X. et al. (2008) ‘The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1’, Journal of Neuroscience, 28(5), pp. 1213–1223. doi: 10.1523/JNEUROSCI.5065-07.2008.
Wang, X. et al. (2009) ‘miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer’s disease, inhibits bcl2 translation’, Brain Research Bulletin, 80(4–5), pp. 268–273. doi: 10.1016/j.brainresbull.2009.08.006.
Wu, C. Y. C. et al. (2018) ‘Utilizing the modified T-maze to assess functional memory outcomes after cardiac arrest’, Journal of Visualized Experiments. Journal of Visualized Experiments, 2018(131). doi: 10.3791/56694.
Zameer, S. et al. (2019) ‘Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Aβ and BACE-1’, NeuroToxicology. Elsevier B.V., 70, pp. 122–134. doi: 10.1016/j.neuro.2018.11.012.
Zameer, S. and Vohora, D. (2017) ‘Effect of aromatase inhibitors on learning and memory and modulation of hippocampal dickkopf-1 and sclerostin in female mice’, Pharmacological Reports, 69(6), pp. 1300–1307. doi: 10.1016/j.pharep.2017.06.002.
Zhu, H. et al. (2011) ‘The Lin28/let-7 axis regulates glucose metabolism.’, Cell. NIH Public Access, 147(1), pp. 81–94. doi: 10.1016/j.cell.2011.08.033.